Home
>
US Stocks
>
Rubius Therapeutics Inc
Rubius Therapeutics Inc
RUBY

Rubius Therapeutics Inc (RUBY)

$14.585.14%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open$14.42
Today Low/High$13.76 / $14.61
52 Week Low/High$4.2 / $38.71
Market Cap$1.29B

Company Details

Rubius Therapeutics is a clinical-stage biopharmaceutical company developing a new class of medicines called Red Cell Therapeutics™. The Company's proprietary RED PLATFORM® was designed to genetically engineer and culture Red Cell Therapeutics™ that are selective, potent and off-the-shelf allogeneic cellular therapies for the potential treatment of several diseases across multiple therapeutic areas.
OrganisationRubius Therapeutics Inc
HeadquatersCambridge, Massachusetts, US
Employees204
IndustryHealth Technology
CEOPablo Cagnoni

Discover more

Frequently Asked Questions

What is Rubius Therapeutics Inc (RUBY) share price today?

Can Indians buy Rubius Therapeutics Inc (RUBY) shares?

How can I buy Rubius Therapeutics Inc (RUBY) shares from India?

Can Fractional shares of Rubius Therapeutics Inc (RUBY) be purchased?

What are the documents required to start investing in Rubius Therapeutics Inc (RUBY) stocks?

We are a SEBI registered investement advisor